Immunohistochemical staining of different macrophage markers across gliomas showed a higher expression of the M2 marker CD163 in pilocytic astrocytoma (WHO grade I) compared to diffuse astrocytomas and GBM. The gene discussed is CD163; the disease is glioblastoma.